Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Apr 16;8(8):e011799.
doi: 10.1161/JAHA.118.011799.

Using mH ealth Tools to Improve Access and Coverage of People With Public Health Insurance and High Cardiovascular Disease Risk in Argentina: A Pragmatic Cluster Randomized Trial

Andrea Beratarrechea  1 , Shafika Abrahams-Gessel  2 , Vilma Irazola  1 , Laura Gutierrez  1 , Daniela Moyano  1 , Thomas A Gaziano  2   3
Affiliations
Randomized Controlled Trial

Using mH ealth Tools to Improve Access and Coverage of People With Public Health Insurance and High Cardiovascular Disease Risk in Argentina: A Pragmatic Cluster Randomized Trial

Andrea Beratarrechea et al. J Am Heart Assoc. .

Abstract

Background Control of cardiovascular disease ( CVD ) risk factors is suboptimal in Argentina, despite the government's provision of free blood pressure and cholesterol-lowering medications for people without private insurance. We assessed whether community health workers' use of an integrated mH ealth tool encourages patients to attend visits at primary care clinics to improve CVD risk management in 2 provinces of Argentina. Methods and Results We conducted a pragmatic cluster randomized trial, with primary care clinics randomly assigned to intervention or control. Eligible people were aged 40 to 79 years, lived in the catchment area of primary care clinics, possessed a mobile phone for personal use, had public health coverage, and a 10-year CVD risk ≥10%. In the control arm, community health workers screened for CVD risk using a paper-based tool and encouraged high-risk people to present to the primary care clinics for care. In the intervention arm, community health workers used the mH ealth tool to calculate CVD risk and confirm a scheduled physician appointment. Primary outcomes were the proportion of participants who attended a baseline visit and completed at least 1 follow-up, respectively. We enrolled 755 people (376 interventions; 379 controls). Intervention participants were significantly more likely to complete baseline visits (49.4% versus 13.5%, P value 0.0008) and follow-up visits (31.9% versus 7.7%; P value 0.0041). The use of chronic medication and current smoking were significant predictors of primary outcomes. Conclusions Use of mH ealth tools identifies patients at high CVD risk in their home, increases the likelihood of participating in chronic CVD risk factor management, and strengthens referrals. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02913339.

Trial registration: ClinicalTrials.gov NCT02913339.

Keywords: Argentina; cardiovascular; mHealth; prevention; screening.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Process flow in the intervention arm. CHW indicates community health worker; CVD, cardiovascular disease; PCC, primary care center; WHO, World Health Organization.
Figure 2
Figure 2
Flow diagram of trial participants.
See this image and copyright information in PMC

References

    1. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J; Lancet NCDAG, Alliance NCD . Priority actions for the non‐communicable disease crisis. Lancet. 2011;377:1438–1447. - PubMed
    1. Rubinstein A, Colantonio L, Bardach A, Caporale J, Garcia Marti S, Kopitowski K, Alcaraz A, Gibbons L, Augustovski F, Pichon‐Riviere A. Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina. Rev Panam Salud Publica. 2010;27:237–245. - PubMed
    1. World Health Organisation . Global status report on noncommunicable disease 2010: description of the global burden of NCDs, their risk factors and determinants. 2011:176.
    1. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost‐effectiveness analysis. Lancet. 2006;368:679–686. - PMC - PubMed
    1. Tsolekile LP, Abrahams‐Gessel S, Puoane T. Healthcare professional shortage and task‐shifting to prevent cardiovascular disease: implications for low‐ and middle‐income countries. Curr Cardiol Rep. 2015;17:115. - PubMed

Publication types

MeSH terms

Associated data